Vitrification for Ovarian Tissue Harvesting
Testing of Vitrification Protocols for Ovarian Tissue Harvesting in Female to Male Transsexuals
1 other identifier
interventional
10
1 country
1
Brief Summary
Increasing interest has emerged concerning ovarian tissue cryopreservation and subsequent transplantation as a potential way of preserving fertility in cancer patients as well as for women who just wish to delay childbearing. As the majority of existing protocols use the slow freezing method, this study aims to test vitrification techniques of ovarian cortex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 29, 2017
CompletedFirst Posted
Study publicly available on registry
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedAugust 28, 2018
August 1, 2018
1 year
October 29, 2017
August 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
survival of ovarian tissue
histologic and enzymatic evaluation of ovarian tissue with respect to survival and functionality of ovarian follicles
2 days until 2 years after freezing
Interventions
Vitrification of ovarian tissue
Eligibility Criteria
You may qualify if:
- female-to-male transsexuals
- gender completing operation
- signed informed consent form
- willingness to donate ovarian tissue for research purposes
- age \>=18 years
You may not qualify if:
- malignant disease
- age under 18 years
- refusal to donate ovarian tissue
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinic of Obstetrics and Gynaecology of the Medical University of Vienna
Vienna, 1090, Austria
Related Publications (2)
Marschalek J, Egarter C, Nouri K, Dekan S, Ott J, Frank M, Pietrowski D. The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study. J Ovarian Res. 2021 Dec 6;14(1):170. doi: 10.1186/s13048-021-00924-8.
PMID: 34872604DERIVEDMarschalek J, Pietrowski D, Dekan S, Marschalek ML, Brandstetter M, Ott J. Markers of vitality in ovaries of transmen after long-term androgen treatment: a prospective cohort study. Mol Med. 2020 Sep 5;26(1):83. doi: 10.1186/s10020-020-00214-x.
PMID: 32891132DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 29, 2017
First Posted
August 28, 2018
Study Start
October 1, 2017
Primary Completion
October 1, 2018
Study Completion
December 1, 2018
Last Updated
August 28, 2018
Record last verified: 2018-08